MODERATOR
:
SPEAKER
(S):
Neil Blumberg, MD, Professor of Pathology & Laboratory Medicine, University of Rochester Medical Center
New Issues Regarding Platelet Transfusion Side Effects
Ronald Strauss, MD, Professor Emeritus of Pathology & Pediatrics, University of Iowa College of Medicine, Associate Medical Director, LifeSource/ITxM (Chicago)
Selecting Pretransfusion Trigger, Platelet Does & Platelet Product For Prophylactic Platelet Transfusions
Elisabeth Maurer-Spurej, PhD, Chief Technology Officer, LightIntegra Technology Inc
Opportunities for cost savings
Description
In times of extreme financial pressure on health-care providers, costs are critically important. This session will shed some light on the costs involved in producing, using and discarding platelet transfusions. Questions the speakers will try to answer are: what is the cost of platelet concentrates produced by different methods; what is the cost of providing platelets to hospitals; what is the cost of expired product; what factors drive the cost of platelet support at hospitals; how are different platelet products and their use modalities affecting patient outcome; where are the opportunities for cost savings and improvement?
-
Discuss different options to reduce cost and the effect of cost reduction efforts on supply of platelet concentrates and on patient outcome.
-
Discuss the use of platelet transfusions with a focus on hematologic malignancies and surgery and assess the cost of different platelet support strategies depending on the outcome measures.
-
Evaluate different production methods and treatment technologies for platelet concentrates and their cost effectiveness.
CE Category | CE Value |
---|
California Clinical Laboratory Personnel |
1.5 |
California Nurse |
1.8 |
Florida Laboratory Personnel |
1.8 |
General Attendee |
1.5 |
Physician |
1.5 |
Please note: Continuing education (CE) credit is available for online offerings only. Individuals that purchase CD-ROMs will not receive CE credit for the programs they view.